SEARCH

SEARCH BY CITATION

References

  • 1
    Boom WH. The role of T cell subsets in Mycobacterium tuberculosis infection. Infect Agents Dis 1996; 5 : 7381.
  • 2
    Cooper AM, Saunders BM, D'Souza CD, Frank AA, Orme IM. Mycobacterium tuberculosis-driven processes in gene-disrupted mice. Bull Inst Pasteur 1997; 95 : 8595.
  • 3
    Mogues T, Goodrich ME, Ryan L, LaCourse R, North RJ. The relative importance of T cell subsets in immunity and immunopathology of airborne Mycobacterium tuberculosis infection in mice. J Exp Med 2001; 193 : 27180.
  • 4
    Shiloh MU, Nathan DF. Reactive nitrogen intermediates and the pathogenesis of Salmonella and mycobacteria. Curr Opin Microbiol 2000; 3 : 3542.
  • 5
    Cooper AM, Dalton DK, Stewart TA, Griffin JP, Russell DG, Orme IM. Disseminated tuberculosis in IFN-γ gene disrupted mice. J Exp Med 1993; 178 : 22437.
  • 6
    Flynn JL, Chan J, Triebold KJ, Dalton DK, Stewart TA, Bloom BR. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J Exp Med 1993; 178 : 224954.
  • 7
    MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci USA 1997; 94 : 52438.
  • 8
    Power CA, Wei G, Bretscher PA. Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by intravenous, subcutaneous, or intradermal route. Infect Immun 1998; 66 : 574350.
  • 9
    Hernandez-Pando R, Orozcoe H, Sampieri A, Pavon L, Velasquillo C, Larriva-Sahd J, Alcocer JM, Madrid MV. Correlation between the kinetics of Th1, Th2 cells and pathology in a murine model of experimental pulmonary tuberculosis. Immunology 1996; 89 : 2633.
  • 10
    Reiner SL, Locksley RM. The regulation of immunity to Leishmania major. Annu Rev Immunol 1995; 13 : 15177.
  • 11
    Jung Y-J, LaCourse R, Ryan L, North RJ. Evidence inconsistent with a negative influence of T helper 2 cells on protection afforded by a dominant T helper 1 response against Mycobacterium tuberculosis lung infection in mice. Infect Immun 2002; 70 : 643643.
  • 12
    Moore KW, DeWaal Malefyt R, Coffman RL, O'Garra A. Interleukin-10. Annu Rev Immunol 1993; 11 : 16590.
  • 13
    Redpath S, Ghazal P, Gascoigne NR. Hijacking and exploitation of IL-10 by intracellular pathogens. Trends Microbiol 2001; 9 : 8692.
  • 14
    Belkaid Y, Hoffmann KF, Mendez S, Kamhawi S, Udey MC, Wynn TA, Sacks DL. The role of (IL)-10 in persistence of Leishmania major infection in the skin after healing and the therapeutic potential of any IL-10 receptor antibody for sterile cure. J Exp Med 2001; 194 : 1497506.
  • 15
    Lang R, Patel D, Morris JJ, Rutschman RL, Young PJ. Shaping gene expression in activated and resting primary macrophages by IL-10. J Immunol 2002; 169 : 225363.
  • 16
    Flesch IE, Hess JH, Oswald IP, Kaufmann SH. Growth inhibition of Mycobacterium bovis by IFN-γ-stimulated macrophages: regulation by endogenous tumor necrosis factor and by IL-10. Int Immunol 1993; 6 : 693700.
  • 17
    Murray PJ, Young RA. Increased antimycobacterial immunity in interleukin-10-deficient mice. Infect Immun 1999; 67 : 3087305.
  • 18
    Jacobs M, Brown N, Allie N, Gulert R, Ryffel B. Increased resistance to mycobacterial infection in the absence of interleukin-10. Immunology 2000; 100 : 494501.
  • 19
    Murray PJ, Wang L, Onufryk C, Tepper RI, Young RA. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection. J Immunol 1997; 158 : 31521.
  • 20
    Lang R, Rutschman RL, Greives DR, Murray PJ. Autocrine deactivation of macrophages in transgenic mice constitutively over-expressing IL-10 under control of the CD68 promoter. J Immunol 2002; 168 : 340211.
  • 21
    Bermudez LE, Champsi J. Infection with Mycobacterium avium induces production of interleukin-10 (IL-10), and administration of anti-IL-10 antibody is associated with enhanced resistance to infection in mice. Infect Immun 1992; 61 : 30937.
  • 22
    Denis M, Ghadirian E. IL-10 neutralization augments mouse resistance to systemic Mycobacterium avium infection. J Immunol 1993; 151 : 542530.
  • 23
    Roach DR, Martin E, Bean AG, Renick DM, Briscoe H, Britton WJ. Endogenous inhibition of antimycobacterial immunity by IL-10 varies between mycobacterial species. Scand J Immunol 2001; 54 : 16370.
  • 24
    Turner J, Gonzalez-Juarrero M, Ellis DL, Basaraba RJ, Kipnis A, Orme IM, Cooper AM. In vivo IL-10 production reactivates chronic pulmonary tuberculosis in C57BL/6 mice. J Immunol 2002; 169 : 634351.
  • 25
    North RJ. Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis. Clin Exp Immunol 1998; 113 : 558.
  • 26
    Gerosa F, Nisii C, Righetti S, Micciolo R, Marchesini M, Cazzadori A, Trinchieri G. CD4+ T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchiolar lavages of active pulmonary tuberculosis patients. Clin Immunol 1999; 92 : 22434.
  • 27
    Gong JH, Zhang M, Modlin RL, Linsley PS, Iyer D, Lin Y, Barnes PF. Interleukin-10 downregulates Mycobacterium tuberculosis-induced responses and CTLA-4 expression. Infect Immun 1996; 64 : 9138.
  • 28
    Boussiotis VA, Tsai EY, Yunis EJ et al. IL-10-producing T cells suppress response in anergic tuberculosis patients. J Clin Invest 2000; 105 : 131725.
  • 29
    Cooper AM, Magram J, Ferrante J, Orme IM. Interleukin-12 (IL-12) is crucial for the development of protective immunity in mice intravenously infected with Mycobacterium tuberculosis. J Exp Med 1997; 186 : 3945.
  • 30
    Park AY, Hondowicz BD, Scott P. IL-12 is required to maintain a Th1 response during Leishmania major infection. J Immunol 2000; 165 : 896902.
  • 31
    Stobie L, Gurunathan S, Prussin C, Sacks DL, Glaichenhaus N, Wu CY, Seder RA. The role of antigen and IL-12 in sustaining Th1 memory cells in vivo: IL-12 is required to maintain memory/effector Th1 cells sufficient to mediate protection to an infectious parasitic challenge. Proc Natl Acad Sci USA 2000; 97 : 842732.